glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management glp-1_analogs [TUSOM | Pharmwiki]
Description
Gorgojo-Martinez J et al
![glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Muscle recovery was also assessed by evaluating serum creatine kinase levels
![glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management glp-1_analogs [TUSOM | Pharmwiki]](https://assets.medpagetoday.net/media/images/100xxx/100492.jpg?width=0.8)
Your provider should establish a baseline monitoring schedule
![glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41366-024-01473-y/MediaObjects/41366_2024_1473_Fig1_HTML.png)
The four-week hold per step is not arbitrary it matches the interval at which GI adverse events subside as the gut adapts
![glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management glp-1_analogs [TUSOM | Pharmwiki]](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2026/06/holding-GLP-1RA-syringe-1296x728-header-1024x575.jpg)
Real-world trends in GLP-1 treatment persistence and prescribing for weight management.
![glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.sanity.io/images/0vv8moc6/oncnurse/a3bbe8d1d52435239659c10c2c20ae54decbdf8d-1024x1024.png/Gemini_Generated_Image_sbdnfmsbdnfmsbdn.png?w=1024&max-h=1024&fit=crop&auto=format)